Skip to content

Effects of Advanced Platelet-Rich Fibrin Plus combine with injectable Platelet-Rich Fibrin on clinical outcomes following surgical removal of the lower third molar: A split-mouth randomized controlled crossover study

Effects of Advanced Platelet-Rich Fibrin Plus combine with injectable Platelet-Rich Fibrin on clinical outcomes following surgical removal of the lower third molar: A split-mouth randomized controlled crossover study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260603007
Enrollment
17
Registered
2026-06-03
Start date
2026-03-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy patients requiring surgical removal of identical bilateral lower third molar impaction Post-op surgical removal of impacted lower third molars Combined-PRF

Interventions

Preparation of platelet concentrate for the intervention arm. Blood collection will be similar to a routine blood test procedure from the antecubital region. A total of 20 mL of blood will be drawn fo
Experimental Procedure/Surgery,No Intervention Procedure/Surgery
Standard treatment with application of APRF plus and iPRF,Standard treatment

Sponsors

Laddawun Sununliganon
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Patients who require surgical removal of identical bilateral impacted lower third molars, 2. Health status is categorized according to the American Society of Anesthesiologists (ASA) as ASA I and ASA II, 3. No history of medication-related osteonecrosis of the jaw or previous radiotherapy in the head and neck area, 4. No drug allergies related to the study, 5. No administration of anti-inflammatory drugs, steroids, or antibiotics within two weeks before the operation, 6. No psychological disorders or mental impairments, 7. No systemic conditions that could affect metabolism and healing responses, 8. Nonsmokers or light smokers (less than 10 cigarettes per day), 9. No history of platelet disorders or use of antiplatelet or anticoagulant therapy, 10. No active inflammation or pathology associated with the impacted tooth, 11. Ability to comply with a follow-up schedule. follow-up schedule

Exclusion criteria

Exclusion criteria: Pregnancy

Design outcomes

Primary

MeasureTime frame
Facial contour Pre-operation, 3 and 7 days post-opertion The distances on the face are defined as H1, H2, and V

Secondary

MeasureTime frame
Pain Pre-op, 3 and 7 days post-operation Visual analog scale,Degree of mouth opening Pre-op, 3 and 7 days post-ioperation Digital caliper measured from tooth 22 to 41,Sign of inflammation Day 3 and 7 post-operation wound color (Red: Yes/No),Patients' satisfaction 7 days post-operation Visual analog scale,Quality of Life (QOL) 7 days post-operation Questionnaires: Postoperative Symptom Severity (PoSSe) scale

Countries

Thailand

Contacts

Public ContactLaddawun Sununliganon

Rangsit University

laddawan.su@rsu.ac.th029972200

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026